QNCX (Quince Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.04 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +0.00% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find QNCX SEC filings?

Rallies organizes QNCX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

QNCX Key Metrics

Key financial metrics for QNCX
MetricValue
Price$1.04
Market Cap$16.22M
P/E Ratio-0.64
EPS$-1.68
Dividend Yield0.00%
52-Week High$45.50
52-Week Low$0.79
Volume97.21K
Avg Volume0
Revenue (TTM)$0
Net Income$-80.77M
Gross Margin0.00%

Latest QNCX News

Recent QNCX Insider Trades

  • Benatti Luca sold 50.00K (~$173.50K) on Dec 26, 2025.
  • Thye Dirk bought 77.00K (~$53.90K) on Aug 30, 2024.
  • Thye Dirk bought 77.50K (~$53.47K) on Aug 29, 2024.

QNCX Analyst Consensus

QNCX analyst coverage data. Average price target: $0.00.

Common questions about QNCX

Where can I find QNCX SEC filings?
Rallies organizes QNCX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show QNCX 10-K and 10-Q filings?
Rallies organizes QNCX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is QNCX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for QNCX. It does not provide personalized investment advice.
QNCX

QNCX